A Modular Lentiviral and Retroviral Construction System to Rapidly Generate Vectors for Gene Expression and Gene Knockdown In Vitro and In Vivo

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Geiling, Benjamin ^a   Vandal, Guillaume ^a   Posner, Ada R ^a   de Bruyns, Angeline ^a   Dutchak, Kendall L ^a   Garnett, Samantha ^a   Dankort, David ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; COMPLEMENTARY DNA; CRE RECOMBINASE; LENTIVIRUS VECTOR; MICRORNA; PROTEIN P53; RETROVIRUS VECTOR; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CONTROLLED STUDY; EXPRESSION VECTOR; GENE CASSETTE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSDUCTION; GENOME ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; RECOMBINANT PLASMID; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; BIOLOGICAL MARKERS; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; LUNG NEOPLASMS; MICE; NIH 3T3 CELLS; RETROVIRIDAE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885416755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076279     Document Type: Article

References (86)

1. Naldini L, Blomer U, Gage FH, Trono D, Verma IM, (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93: 11382-11388.
2. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
3. Fewell GD, Schmitt K, (2006) Vector-based RNAi approaches for stable, inducible and genome-wide screens. Drug Discov Today 11: 975-982.
4. Sakuma T, Barry MA, Ikeda Y, (2012) Lentiviral vectors: basic to translational. Biochem J 443: 603-618.
5. Brummelkamp TR, Bernards R, Agami R, (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
6. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS, (2002) Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958.
7. Dykxhoorn DM, Novina CD, Sharp PA, (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4: 457-467.
8. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P, (2006) A versatile tool for conditional gene expression and knockdown. Nat Methods 3: 109-116.
9. Wiznerowicz M, Szulc J, Trono D, (2006) Tuning silence: conditional systems for RNA interference. Nat Methods 3: 682-688.
10. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ, (2005) A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci U S A 102: 13212-13217.
11. Chang K, Elledge SJ, Hannon GJ, (2006) Lessons from Nature: microRNA-based shRNA libraries. Nat Methods 3: 707-714.
12. Aslanidis C, de Jong PJ, (1990) Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res 18: 6069-6074.
13. Shuman S, (1994) Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase. J Biol Chem 269: 32678-32684.
14. Rashtchian A, (1995) Novel methods for cloning and engineering genes using the polymerase chain reaction. Curr Opin Biotechnol 6: 30-36.
15. Berrow NS, Alderton D, Sainsbury S, Nettleship J, Assenberg R, et al. (2007) A versatile ligation-independent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res 35: e45.
16. Yang J, Zhang Z, Zhang XA, Luo Q, (2010) A ligation-independent cloning method using nicking DNA endonuclease. Biotechniques 49: 817-821.
17. Hartley JL, Temple GF, Brasch MA, (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10: 1788-1795.
18. Nash HA, Mizuuchi K, Enquist LW, Weisberg RA, (1981) Strand exchange in lambda integrative recombination: genetics, biochemistry, and models. Cold Spring Harb Symp Quant Biol 45 Pt 1: 417-428.
19. Bernard P, Couturier M, (1991) The 41 carboxy-terminal residues of the miniF plasmid CcdA protein are sufficient to antagonize the killer activity of the CcdB protein. Mol Gen Genet 226: 297-304.
20. Bernard P, Couturier M, (1992) Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol 226: 735-745.
21. Cheo DL, Titus SA, Byrd DR, Hartley JL, Temple GF, et al. (2004) Concerted assembly and cloning of multiple DNA segments using in vitro site-specific recombination: functional analysis of multi-segment expression clones. Genome Res 14: 2111-2120.
22. Vieira J, Messing J, (1991) New pUC-derived cloning vectors with different selectable markers and DNA replication origins. Gene 100: 189-194.
23. Martin P, Albagli O, Poggi MC, Boulukos KE, Pognonec P, (2006) Development of a new bicistronic retroviral vector with strong IRES activity. BMC Biotechnol 6: 4.
24. Yu SF, von Ruden T, Kantoff PW, Garber C, Seiberg M, et al. (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A 83: 3194-3198.
25. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880.
26. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414.
27. Silva JM, Li MZ, Chang K, Ge W, Golding MC, et al. (2005) Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 37: 1281-1288.
28. Dow LE, Premsrirut PK, Zuber J, Fellmann C, McJunkin K, et al. (2012) A pipeline for the generation of shRNA transgenic mice. Nat Protoc 7: 374-393.
29. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, et al. (2000) Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14: 3037-3050.
30. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, et al. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 92: 7297-7301.
31. Hampf M, Gossen M, (2006) A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays. Anal Biochem 356: 94-99.
32. Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R, (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 282: 158-161.
33. DuPage M, Dooley AL, Jacks T, (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4: 1064-1072.
34. Johnson LG, Vanhook MK, Coyne CB, Haykal-Coates N, Gavett SH, (2003) Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum Gene Ther 14: 729-747.
35. Dankort D, Filenova E, Collado M, Serrano M, Jones K, et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
36. Kamimura K, Suda T, Zhang G, Liu D, (2011) Advances in Gene Delivery Systems. Pharmaceut Med 25: 293-306.
37. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, et al. (2009) A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS ONE 4: e6529.
38. de Felipe P, Luke GA, Hughes LE, Gani D, Halpin C, et al. (2006) E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol 24: 68-75.
39. Trichas G, Begbie J, Srinivas S, (2008) Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biol 6: 40.
40. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, et al. (2001) Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82: 1013-1025.
41. Ryan MD, King AM, Thomas GP, (1991) Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol 72 (Pt 11): 2727-2732.
42. Corish P, Tyler-Smith C, (1999) Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng 12: 1035-1040.
43. Verkhusha VV, Kuznetsova IM, Stepanenko OV, Zaraisky AG, Shavlovsky MM, et al. (2003) High stability of Discosoma DsRed as compared to Aequorea EGFP. Biochemistry 42: 7879-7884.
44. Xue W, Zender L, Miething C, Dickins RA, Hernando E, et al. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660.
45. Vousden KH, Lane DP, (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283.
46. Meek DW, (2009) Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9: 714-723.
47. Lowe SW, Ruley HE, Jacks T, Housman DE, (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
48. Kubbutat MH, Jones SN, Vousden KH, (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303.
49. Tarun SZ Jr, Sachs AB, (1996) Association of the yeast poly(A) tail binding protein with translation initiation factor eIF-4G. Embo J 15: 7168-7177.
50. Le H, Tanguay RL, Balasta ML, Wei CC, Browning KS, et al. (1997) Translation initiation factors eIF-iso4G and eIF-4B interact with the poly(A)-binding protein and increase its RNA binding activity. J Biol Chem 272: 16247-16255.
51. Landthaler M, Yalcin A, Tuschl T, (2004) The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14: 2162-2167.
52. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA, (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A 98: 9742-9747.
53. Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA, (1999) Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev 13: 3191-3197.
54. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
55. Stauffer Y, Raj K, Masternak K, Beard P, (1998) Infectious human papillomavirus type 18 pseudovirions. J Mol Biol 283: 529-536.
56. Hayflick L, Moorhead PS, (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
57. Campisi J, d'Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
58. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
59. Harley CB, Futcher AB, Greider CW, (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460.
60. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
61. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468.
62. Sebastian T, Malik R, Thomas S, Sage J, Johnson PF, (2005) C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. Embo J 24: 3301-3312.
63. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, et al. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.
64. Wadia JS, Dowdy SF, (2002) Protein transduction technology. Curr Opin Biotechnol 13: 52-56.
65. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, et al. (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98: 49-56.
66. Audouy S, Hoekstra D, (2001) Cationic lipid-mediated transfection in vitro and in vivo (review). Mol Membr Biol 18: 129-143.
67. Kovesdi I, Brough DE, Bruder JT, Wickham TJ, (1997) Adenoviral vectors for gene transfer. Curr Opin Biotechnol 8: 583-589.
68. Bitzer M, Armeanu S, Lauer UM, Neubert WJ, (2003) Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med 5: 543-553.
69. Van Craenenbroeck K, Vanhoenacker P, Haegeman G, (2000) Episomal vectors for gene expression in mammalian cells. Eur J Biochem 267: 5665-5678.
70. Wong SP, Argyros O, Coutelle C, Harbottle RP, (2009) Strategies for the episomal modification of cells. Curr Opin Mol Ther 11: 433-441.
71. Smith RH, (2008) Adeno-associated virus integration: virus versus vector. Gene Ther 15: 817-822.
72. Deyle DR, Russell DW, (2009) Adeno-associated virus vector integration. Curr Opin Mol Ther 11: 442-447.
73. Ding S, Wu X, Li G, Han M, Zhuang Y, et al. (2005) Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122: 473-483.
74. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z, (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
75. Mitta B, Rimann M, Ehrengruber MU, Ehrbar M, Djonov V, et al. (2002) Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 30: e113.
76. Wiznerowicz M, Trono D, (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77: 8957-8961.
77. Shin KJ, Wall EA, Zavzavadjian JR, Santat LA, Liu J, et al. (2006) A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci U S A 103: 13759-13764.
78. Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V, (2004) Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci U S A 101: 1927-1932.
79. Kesireddy V, van der Ven PF, Furst DO, (2010) Multipurpose modular lentiviral vectors for RNA interference and transgene expression. Mol Biol Rep 37: 2863-2870.
80. Weber K, Bartsch U, Stocking C, Fehse B, (2008) A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol Ther 16: 698-706.
81. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, et al. (2011) The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci U S A 108: 3665-3670.
82. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, et al. (2007) The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236: 3088-3099.
83. Walhout AJ, Temple GF, Brasch MA, Hartley JL, Lorson MA, et al. (2000) GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol 328: 575-592.
84. Shaner NC, Steinbach PA, Tsien RY, (2005) A guide to choosing fluorescent proteins. Nat Methods 2: 905-909.
85. Kitamura T, Onishi M, Kinoshita S, Shibuya A, Miyajima A, et al. (1995) Efficient screening of retroviral cDNA expression libraries. Proc Natl Acad Sci U S A 92: 9146-9150.
86. Chen Y, Gorski DH, (2008) Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111: 1217-1226.